BWFG vs NBIX · P/E 11, rev $1.4M vs P/E 45, rev $1.77B
Bankwell Financial Group Inc (BWFG) versus Neurocrine Biosciences Inc (NBIX) — a side-by-side from cached financials, not a winner call.
Bankwell Financial Group Inc (BWFG) is a banks - regional company listed on US.
Neurocrine Biosciences Inc (NBIX) is a drug manufacturers - specialty & generic company listed on US.
Latest reported BWFG revenue for 2026-06-30 was $1.4M. Net income was $23.6M. Revenue was up 85.3% from 2026-03-31 to 2026-06-30. BWFG currently screens at market cap $427.9M and trailing P/E 10.8.
Latest reported NBIX revenue for 2026-06-30 was $1.77B. Net income was $342.3M. NBIX currently screens at market cap $13.21B and trailing P/E 45.2.
BWFG currently screens at market cap $427.9M and trailing P/E 10.8. NBIX currently screens at market cap $13.21B and trailing P/E 45.2.
Not investment advice. Open the BWFG and NBIX stock pages for the full models.
Not investment advice.